Li Li
17PUBLICATIONS
20CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (17)
Sort by Publication Date:
|Feb 27, 2026
NSD2 inhibits the expression of PD-L1 via oxidative phosphorylation to control immune surveillance in hepatocellular carcinoma.Wei Zhang, Wenxin Feng, Chunxiao Ma
|Feb 26, 2026
Histone 3 lysine 36 trimethylation by SETD2 shapes an epigenetic landscape in intestinal stem cells to orchestrate lipid metabolism and attenuate cell senescence.Yue Xu, Ziyi Wang, Wenxin Feng
|Jan 05, 2026
Ribosome Homeostasis Regulated by SETD2 Preserves Intestinal Epithelial Barrier.Hanyu Rao, Aiting Wang, Yue Xu
|Jul 22, 2025
NSD2 promotes cell durotaxis and drives the transition from polycystic kidney disease to tubulocystic renal cell carcinoma through integrin/FAK/AKT signaling.Wenxin Feng, Ningyuan Liu, Changwei Liu
|Dec 10, 2024
Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruption.Yue Xu, Xiuying Xiao, Chunxiao Ma
Pageof 3
Frequent Collaborators
5 joint publications
Wei-Qiang Gao
3 joint publications
Xiuying Xiao
2 joint publications
Min Wu
2 joint publications
Wei Li
1 joint publications
Louis Lefebvre
1 joint publications
Matthew C Lorincz
1 joint publications
Wei Xie
1 joint publications
Zhongzhong Ji
1 joint publications
Helen He Zhu
1 joint publications
Da Fu